Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 35 Similar Profiles
Head and Neck Neoplasms Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neck Medicine & Life Sciences
Oropharyngeal Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Laryngeal Neoplasms Medicine & Life Sciences
Organ Preservation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2000 2024

Research Output 1994 2017

  • 4836 Citations
  • 32 Scopus h-Index
  • 117 Article
  • 18 Review article
  • 4 Comment/debate
  • 1 Letter

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers

Siddiqui, F., Smith, R. V., Yom, S. S., Beitler, J. J., Busse, P. M., Cooper, J. S., Hanna, E. Y., Jones, C. U., Koyfman, S. A., Quon, H., Ridge, J. A., Saba, N. F., Worden, F., Yao, M., Salama, J. K. & Expert Panel on Radiation Oncology – Head and Neck Cancer Mar 1 2017 In : Head and Neck. 39, 3, p. 407-418 12 p.

Research output: Contribution to journalArticle

Paranasal Sinus Neoplasms
Paranasal Sinuses
Nasal Cavity
Radiology
Nose Neoplasms

Buparlisib—and the continued quest for the ideal cure

Worden, F. P. Mar 1 2017 In : The Lancet Oncology. 18, 3, p. 273-274 2 p.

Research output: Contribution to journalComment/debate

Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients

Kudrimoti, M., Curtis, A., Azawi, S., Worden, F., Katz, S., Adkins, D., Bonomi, M., Scott, Z., Elder, J., Sonis, S. T., Straube, R. & Donini, O. Sep 1 2017 In : Biotechnology Reports. 15, p. 24-26 3 p.

Research output: Contribution to journalArticle

Stomatitis
Head and Neck Neoplasms
Mortality
Neoplasms
Innate Immunity
Squamous Cell Carcinoma
Biological Markers
Recurrence
Antibodies
Serum

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Harrington, K. J. , Ferris, R. L. , Blumenschein, G. , Colevas, A. D. , Fayette, J. , Licitra, L. , Kasper, S. , Even, C. , Vokes, E. E. , Worden, F. , Saba, N. F. , Kiyota, N. , Haddad, R. , Tahara, M. , Grünwald, V. , Shaw, J. W. , Monga, M. , Lynch, M. , Taylor, F. , DeRosa, M. & 4 others Morrissey, L., Cocks, K., Gillison, M. L. & Guigay, J. Aug 1 2017 In : The Lancet Oncology. 18, 8, p. 1104-1115 12 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Neck
Quality of Life
Health
Neoplasms